Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms.

In English

Författare

Summary, in English

Objective: The concentration of the complex between activated protein C (APC) and protein C inhibitor (PCI) is a measure of thrombin generation. We studied whether it can provide information useful for the diagnosis and treatment of arterial vascular disease. Methods: Blood was obtained from 429 vascular patients admitted consecutively during September 2004 to March 2005. The APC-PCI complex was measured by using a sandwich immunofluorometric method. The patients were divided into cohorts according to the planned treatment and compared with a control group of healthy individuals. Results: The APC-PCI complex concentration varied from 0.08 to 2.50 mu g/L. In the cohort of patients with aortic aneurysms (n = 78), the median APC-PCI value was 0.45 (10(th) to 90(th) percentile, 0.24-1.47), and values were clearly increased compared with all other cohorts (P <.0001). Patients with carotid disease (n = 73) yielded a median of 0.22 (10(th) to 90(th) percentile, 0.15-0.48). The median for claudicants (n = 74) was 0.26 mu g/L (10(th) to 90(th) percentile, 0.15-0.75), which was higher than in those (n = 97) with critical ischemia (0.20; 10(th) to 90(th) percentile, 0.13-0.36; P <.0023). The cohort with other forms of antherosclerotic disease (n = 40) had a median of 0.23 (10(th) to 90(th) percentile, 0.14-0.42), whereas the value for a cohort of 21 patients with venous disease was 0.19 (10(th) to 90(th) percentile, 0.10-0.34). The median was 0.15 (10(th) to 90(th) percentile, 0.10-0.23) for the control group (n = 121). Conclusions: Patients with atherosclerosis had an increased APC-PCI concentration that corresponded to increased generation of thrombin. Patients with aortic aneurysm had a threefold higher median concentration than the control group. We suggest that this remarkable increase is caused by the local activation of coagulation, and we surmise that APC-PCI measurements can be used as a screening tool to identify patients with aortic aneurysms.

Publiceringsår

2006

Språk

Engelska

Sidor

935-939

Publikation/Tidskrift/Serie

Journal of Vascular Surgery

Volym

43

Issue

5

Dokumenttyp

Artikel i tidskrift

Förlag

Mosby-Elsevier

Ämne

  • Cardiac and Cardiovascular Systems

Nyckelord

  • Aortic Aneurysm
  • 80 and over
  • Intermittent Claudication: blood
  • Humans
  • Female
  • Enzyme Activation
  • Cohort Studies
  • Carotid Stenosis: diagnosis
  • Carotid Stenosis: blood
  • Biological Markers: blood
  • Atherosclerosis: diagnosis
  • Atherosclerosis: blood
  • Abdominal: diagnosis
  • Abdominal: blood
  • Aged
  • Adult
  • Intermittent Claudication: diagnosis
  • Ischemia: diagnosis
  • Ischemia: blood
  • Leg: blood supply
  • Male
  • Mass Screening
  • Middle Aged
  • Predictive Value of Tests
  • Protein C: metabolism
  • Protein C Inhibitor: blood
  • Reference Values
  • Research Support
  • Non-U.S. Gov't
  • Statistics
  • Thrombin: metabolism

Status

Published

Forskningsgrupp

  • Vascular Diseases - Clinical Research
  • Clinical Chemistry, Malmö

ISBN/ISSN/Övrigt

  • ISSN: 1097-6809